INS and diabetes mellitus: Previous studies that explored SIRT1 in diabetes have focussed on type 2 diabetes, showing that SIRT1 activation enhances ß-cell function, improves insulin sensitivity and increases ß cell mass to attenuate hyperglycaemia4,5.